Kangji Medical Holdings Ltd. has disclosed recent internal dealings involving J.P. Morgan Securities PLC, a Class (5) associate connected with the Offeror. On 5 September 2025, J.P. Morgan Securities PLC issued a derivative involving 23,500 reference securities, maturing on 10 February 2026, with a total amount of $207,427.45 paid. The same day, a closing out of a derivative contract involving 500 reference securities was conducted, maturing on 29 December 2025, with a total amount of $4,393.30 received. Additionally, J.P. Morgan Securities PLC issued further derivatives: one involving 351,000 reference securities maturing on 7 October 2026, and another involving 141,000 reference securities maturing on 3 November 2026, with total amounts of $3,101,252.78 and $1,242,766.81 paid, respectively. These dealings were made for the account of J.P. Morgan Securities PLC, which is ultimately owned by JPMorgan Chase & Co.